RESLIZUMAB

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Approval Year

Name

Type

Language

RESLIZUMAB

Official Name

English

MAB HUMAN (IGG4) ANTI P05113 (IL5_HUMAN) (SCH55700)

Common Name

English

reslizumab [INN]

Common Name

English

Immunoglobulin G4, anti-(human interleukin 5) (human-rat monoclonal SCH 55700 γ4-chain), disulfide with human-rat monoclonal SCH 55700 light chain, dimer

Common Name

English

RESLIZUMAB [MI]

Common Name

English

CEP-38072

Code

English

DCP-835

Code

English

SCH55700

Code

English

RESLIZUMAB [USAN]

Common Name

English

CINQAIR

Brand Name

English

Reslizumab [WHO-DD]

Common Name

English

RESLIZUMAB [PURPLE BOOK CDER]

Common Name

English

SCH-55700

Code

English

DCP 835

Code

English

Classification Tree Code System Code

FDA ORPHAN DRUG

328510

Created by admin on Sat Dec 16 17:48:27 GMT 2023 , Edited by admin on Sat Dec 16 17:48:27 GMT 2023

FDA ORPHAN DRUG

237507

Created by admin on Sat Dec 16 17:48:27 GMT 2023 , Edited by admin on Sat Dec 16 17:48:27 GMT 2023

NDF-RT

N0000191872

Created by admin on Sat Dec 16 17:48:27 GMT 2023 , Edited by admin on Sat Dec 16 17:48:27 GMT 2023

WHO-ATC

R03DX08

Created by admin on Sat Dec 16 17:48:27 GMT 2023 , Edited by admin on Sat Dec 16 17:48:27 GMT 2023

NCI_THESAURUS

C20401

Created by admin on Sat Dec 16 17:48:27 GMT 2023 , Edited by admin on Sat Dec 16 17:48:27 GMT 2023

NCI_THESAURUS

C29712

Created by admin on Sat Dec 16 17:48:27 GMT 2023 , Edited by admin on Sat Dec 16 17:48:27 GMT 2023

Code System Code Type Description

NCI_THESAURUS

C152197

Created by admin on Sat Dec 16 17:48:27 GMT 2023 , Edited by admin on Sat Dec 16 17:48:27 GMT 2023

PRIMARY

USAN

LL-65

Created by admin on Sat Dec 16 17:48:27 GMT 2023 , Edited by admin on Sat Dec 16 17:48:27 GMT 2023

PRIMARY

DRUG CENTRAL

5093

Created by admin on Sat Dec 16 17:48:27 GMT 2023 , Edited by admin on Sat Dec 16 17:48:27 GMT 2023

PRIMARY

DRUG BANK

DB06602

Created by admin on Sat Dec 16 17:48:27 GMT 2023 , Edited by admin on Sat Dec 16 17:48:27 GMT 2023

PRIMARY

INN

8106

Created by admin on Sat Dec 16 17:48:27 GMT 2023 , Edited by admin on Sat Dec 16 17:48:27 GMT 2023

PRIMARY

RXCUI

1746889

Created by admin on Sat Dec 16 17:48:27 GMT 2023 , Edited by admin on Sat Dec 16 17:48:27 GMT 2023

PRIMARY

EVMPD

SUB96120

Created by admin on Sat Dec 16 17:48:27 GMT 2023 , Edited by admin on Sat Dec 16 17:48:27 GMT 2023

PRIMARY

FDA UNII

35A26E427H

Created by admin on Sat Dec 16 17:48:27 GMT 2023 , Edited by admin on Sat Dec 16 17:48:27 GMT 2023

PRIMARY

DAILYMED

35A26E427H

Created by admin on Sat Dec 16 17:48:27 GMT 2023 , Edited by admin on Sat Dec 16 17:48:27 GMT 2023

PRIMARY

SMS_ID

100000141689

Created by admin on Sat Dec 16 17:48:27 GMT 2023 , Edited by admin on Sat Dec 16 17:48:27 GMT 2023

PRIMARY

MERCK INDEX

m9543

Created by admin on Sat Dec 16 17:48:27 GMT 2023 , Edited by admin on Sat Dec 16 17:48:27 GMT 2023

PRIMARY

Merck Index

CAS

241473-69-8

Created by admin on Sat Dec 16 17:48:27 GMT 2023 , Edited by admin on Sat Dec 16 17:48:27 GMT 2023

PRIMARY

LACTMED

Reslizumab

Created by admin on Sat Dec 16 17:48:27 GMT 2023 , Edited by admin on Sat Dec 16 17:48:27 GMT 2023

PRIMARY

ChEMBL

CHEMBL2107884

Created by admin on Sat Dec 16 17:48:27 GMT 2023 , Edited by admin on Sat Dec 16 17:48:27 GMT 2023

PRIMARY

NDF-RT

N0000191871

Created by admin on Sat Dec 16 17:48:27 GMT 2023 , Edited by admin on Sat Dec 16 17:48:27 GMT 2023

PRIMARY

Interleukin-5 Antagonists [MoA]

WIKIPEDIA

RESLIZUMAB

Created by admin on Sat Dec 16 17:48:27 GMT 2023 , Edited by admin on Sat Dec 16 17:48:27 GMT 2023

PRIMARY

ACTIVE MOIETY


					35A26E427H